Gaush Meditech Ltd. has announced the renewal of its exclusive distribution agreement with Schwind eye-tech-solutions GmbH, a Germany-based manufacturer specializing in refractive surgery devices. Under the renewed agreement, Gaush Meditech's subsidiary, Mingwang Medical Ltd., will continue to be responsible for the sales, promotion, and related services of Schwind's products in Mainland China, Hong Kong, and Macau. The collaboration between the two companies began in 2009 and has now been extended to further strengthen Gaush Meditech's position in the Chinese refractive surgery device market. Schwind's portfolio includes the ATOS personalized navigation femtosecond laser and the AMARIS excimer laser series, which are widely used in clinical practices globally. The company stated that this renewed partnership is expected to bring additional opportunities for growth. Shareholders and potential investors have been advised to exercise caution when dealing in the company's shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gaush Meditech Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.
